Alps Group Inc
About Alps Group Inc
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $118.1M
- Operating margin
- 30.1%
- Net margin
- 23.9%
Financial statements
Income statement
- Revenue
- $185.6M
- Operating expenses
- $129.7M
- Operating income
- $55.9M
- Income tax
- -$1.9M
- Net income
- $44.4M
- EPS (basic)
- $0.22
- EPS (diluted)
- $0.20
Balance sheet
- Total assets
- $344.1M
- Current assets
- $40.1M
- Total liabilities
- $252.6M
- Current liabilities
- $203.0M
- Shareholders’ equity
- -$16.1M
Cash flow
- Operating cash flow
- $92.9M
- Investing cash flow
- -$212.2M
- Financing cash flow
- $121.2M
- Net cash flow
- $1.9M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $118.1M
- P/E ratio
- 3.6
- EPS (diluted)
- $0.2
- Dividend yield
- 52.5%
- Shares outstanding
- 164.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 31, 2025
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Trading 72% below its 52-week high.
- Pays a dividend yielding about 52.5% annually.
- Valued at a price-to-earnings (P/E) ratio of 3.6.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Alps Group Inc.
Write a review
News about Alps Group Inc
News & sentiment via Polygon.io
